HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chronic Condition OTC Switches May Take Up To Seven Years – Consultant

This article was originally published in The Tan Sheet

Executive Summary

Clinical studies of Rx-to-OTC switch candidates that target chronic conditions may take 12-24 months longer to conduct than traditional study regimens for acute OTCs, consultant Robert Boggs, PhD, Waife & Associates, observes
Advertisement

Related Content

Rx-To-OTC “Switchability” Initiation Rights May Require Legislation – Juhl
Rx-To-OTC “Switchability” Initiation Rights May Require Legislation – Juhl

Topics

Advertisement
UsernamePublicRestriction

Register

PS094554

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel